Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.
This combination of email and password didn't match our records. Your account might not be activated. If so, please click on the link we sent you via email. You can also request a password reset or a new activation email using the links below.
MORE FILTERS
12% organic sales growth y-o-y.Opex increase and IAC affect Q4. Profitability assumptions down on slightly higher opex.
15% organic sales growth y-o-y. Inera volumes slightly delayed. Minimal changes to long-term estimates.
Solid sales growth at 10.4% y-o-y, all organic. EBIT growth of 28% with excellent cost control. Demand holding up well into H2.
Sales growth below 10% again, but comps were tough. Delivers 18% EBIT growth y-o-y. DOCS sales have stabilised the gross margin.
Save your current filters as a new Interest
Would you like to receive real-time email alerts when a new report is published under this interest?
These search results will show up under 'Saved searches' in the left panel
Would you like to receive real-time email when a new report matches this search?
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.